Triple

T7110960
Position Surface form Disambiguated ID Type / Status
Subject Drug Price Competition and Patent Term Restoration Act of 1984 E165704 entity
Predicate administeredBy P86 FINISHED
Object U.S. Food and Drug Administration E13297 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [Drug Price Competition and Patent Term Restoration Act of 1984, administeredBy, U.S. Food and Drug Administration]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration
Context triple: [Drug Price Competition and Patent Term Restoration Act of 1984, administeredBy, U.S. Food and Drug Administration]
  • A. Food and Drug Administration chosen
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • E. FDA CFSAN
    FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c6888120f081908f8f01b201dc4a4c completed March 27, 2026, 1:39 p.m.
NER Named-entity recognition batch_69c6e5ecd4488190bf19e42de55da98b completed March 27, 2026, 8:17 p.m.
NED1 Entity disambiguation (via context triple) batch_69c7a325a07c81909bd9a8f5d4461fb9 completed March 28, 2026, 9:45 a.m.
Created at: March 27, 2026, 2:43 p.m.